in this issue
Regions :: Western Europe :: Belgium
Solvay to Buy Arkema?
8:33 AM MDT | October 26, 2009 | Ian Young and Natasha Alperowicz
Arkema's share price has been rising for the past month on investor speculation that the company may be an acquisition target for Solvay. The speculation follows Solvay's announcement in September that it has agreed to sell its pharmaceuticals business to Abbott Laboratories for €4.5 billion. Solvay says it plans to reinvest proceeds from the divestment in the company's chemicals and plastics businesses, and analysts say Solvay may use the funds to make a major acquisition. Solvay and Arkema would be a good fit because there are important business overlaps...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee